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Non-invasive and invasive 
diagnoses of aspergillosis in a rat 
model by mass spectrometry
Dominika Luptákováͷ, Tomáš Pluháčekͷ,͸, Miloš Petřík͹, Jiří Novákͷ, Andrea Palyzováͷ,  
Lucie Sokolováͷ, Anton Škríbaͷ, Blanka Šediváͷ,ͺ, Karel Lemrͷ,͸ & Vladimír Havlíček  ͷ,͸
Invasive pulmonary aspergillosis results in ͺͻͶ,ͶͶͶ deaths per year and complicates cancer 
chemotherapy, transplantations and the treatment of other immunosuppressed patients. Using a 
rat model of experimental aspergillosis, the fungal siderophores ferricrocin and triacetylfusarinine C 
were identiied as markers of aspergillosis and quantiied in urine, serum and lung tissues. Biomarkers 
were analyzed by matrix-assisted laser desorption ionization (MALDI) and electrospray ionization 
mass spectrometry using a ͷ͸T SolariX Fourier transform ion cyclotron resonance (FTICR) mass 
spectrometer. The limits of detection of the ferri-forms of triacetylfusarinine C and ferricrocin in the 
rat serum were Ͷ.͸; and Ͷ.͹ͼ ng/mL, respectively. In the rat urine the respective limits of detection 
achieved Ͷ.Ͷ͸ and Ͷ.Ͷ͹ ng/mL. In the sera of infected animals, triacetylfusarinine C was not detected 
but ferricrocin concentration luctuated in the ͹–͹͸ ng/mL range. Notably, the mean concentrations 
of triacetylfusarinine C and ferricrocin in the rat urine were Ͷ.͹ͽ and Ͷ.ͼ͹ µg/mL, respectively. The 
MALDI FTICR mass spectrometry imaging illustrated the actual microbial ferricrocin distribution in the 
lung tissues and resolved the false-positive results obtained by the light microscopy and histological 
staining. Ferricrocin and triacetylfusarinine C detection in urine represents an innovative non-invasive 
indication of Aspergillus infection in a host.
More than 1.6 million people are estimated to die of fungal diseases each year and about a billion people have 
cutaneous fungal infections1. he most common and life-threatening infections are cryptococcosis, candidiasis, 
aspergillosis, blastomycosis, histoplasmosis, coccidioidomycosis, and pneumocystosis2. Fungal infection-related 
deaths in AIDS patients are estimated to be more than 700,000 cases (47% of all HIV-associated deaths) annually3.
Currently, invasive pulmonary aspergillosis (IPA) alone accounts for 450,000 deaths per year2. IPA compli-
cates cancer chemotherapy, particularly in patients with leukemia, transplantations and the treatment of patients 
with other immunosuppressed conditions, including patients with HIV infection. he mortality rates range from 
40% to 90% in high-risk populations and are dependent on factors such as the host immune status, the site of 
infection, and the treatment regimen applied4. Scenarios in which avoidable deaths can be reduced have been 
modeled until 2020 using published outcomes of the real-life impact of diagnostics and generic antifungal drugs3. 
he annual death rates could be reduced if early and reliable diagnostic tools are available. In addition to IPA, 
there are millions of annual cases of allergic bronchopulmonary aspergillosis (ABPA), which may advance to 
chronic pulmonary disease requiring antifungal therapy5. he primary route of human infection is via the inha-
lation of airborne conidia, followed by conidia deposition in the bronchioles or alveolar spaces. he average 
person is estimated to inhale up to 200 A. fumigatus conidia per day6. In IPA-susceptible patient populations, the 
mucosal defense mechanism in the lung is compromised, leading to fungal colonization and growth. By contrast, 
in healthy individuals, conidia that are not removed by mucociliary clearance mechanisms encounter epithelial 
cells and alveolar macrophages that are responsible for phagocytosis and the recruitment of iniltrating neutro-
phils that kill Aspergillus conidia6.
A standard Aspergillus diagnostic approach involves the culture of bronchoalveolar lavage samples; this 
method is sensitive but is invasive and time-consuming. Another invasive but faster diagnostic approach involves 
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the typing of the fungal ribosomal protein equipment using matrix-assisted laser desorption ionization (MALDI) 
proiling, which requires two- to three-day-old cultures, representing a delay that immunosuppressed patients 
cannot aford7. Commercial tools based on DNA typing/PCR or galactomannan serology tests have a lower pre-
dictive value, speciicity and sensitivity8. In (1–3)-β-D-glucan (BG) testing, serology levels exceeding 80 pg/mL 
are considered positive for IPA. However, the Candida, Fusarium and Pneumocystis species also produce BG. 
Another study based on gliotoxin detection in human serum was reported by Cerquieira et al.9. In that study, the 
lower limit of quantitation (LLOQ) using a triple quadrupole mass spectrometer was 10 ng/mL in the multiple 
reaction monitoring mode, and gliotoxin was detected in only eight of thirty samples obtained from patients at 
risk of invasive aspergillosis. herefore, even at the beginning of the 21st century, a sensitive non-invasive tool for 
the early detection and diagnosis of aspergillosis remains lacking10. Furthermore, distinguishing between coloni-
zation (e.g., in ABPA or cystic ibrosis patients) and invasion (IPA) is challenging.
Recently, we described fungal siderophores as speciic markers of fungal infections11; siderophores are iron 
chelators with binding constants of 1020–1050 that are capable of extracting iron, e.g., from host transferrin12. 
Siderophore biosynthesis is important for the virulence of not only A. fumigatus but also of other pathogenic 
microbes, such as Yersinia pestis, Mycobacterium tuberculosis, Bordetella pertussis, Scedosporium apiospermum 
and Pseudomonas aeruginosa13. In our previous ex vivo study, we described the fungal burden in rat lungs using 
elemental mass spectrometry imaging (MSI)13. he iron distributions derived from the fungal siderophores and 
the silver or gold distributions derived using a similar sample staining protocol but speciically incorporated 
into fungal bodies were used as elemental disease descriptors. he limit of detection was determined to be 30 
ng of Au/1 g of lung tissue (with a 5 µm laser focus). At the molecular level, another research group detected 
two siderophores using desorption electrospray mass spectrometry in the wings of bats sufering from white 
nose syndrome14. Both siderophores, i.e., triacetylfusarinine C (TAFC) and ferrichrome, were produced by 
Pseudogymnoascus destructans. In a clinical study, TAFC was also detected in human sera from patients at risk of 
invasive aspergillosis. An LOQ of 5 ng/mL was reported in the multiple reaction monitoring mode using a triple 
quadrupole mass spectrometer15.
In our current work, we provide molecular quantitative data indicating that Aspergillus siderophores are 
efectively secreted in urine during microbial infection and deine these siderophores as non-invasive biomarkers 
of aspergillosis. he siderophore frequencies can be much higher than the frequencies of other small molecules 
that are currently deined as Aspergillus virulence factors, including gliotoxin12. We compared our quantita-
tive results of the distribution of TAFC with that of another Aspergillus siderophore, i.e., ferricrocin (FC), in 
rat serum and lung tissues and showed that these biomarkers are highly sensitive. Furthermore, we report for 
the irst time the molecular MALDI-MSI of these disease biomarkers in lung tissues. he use of Continuous 
Accumulation of Selected Ions (CASI) using a Fourier transform ion cyclotron resonance (FTICR) mass spec-
trometer provided a low detection limit of the siderophores. he structural assessments16 and dereplication of 
the siderophores (i.e., the classiication of already known siderophores) from imzML data and high-performance 
liquid chromatography (HPLC) FTICR datasets were facilitated by our in-house de novo free dereplication tool, 
i.e., CycloBranch17,18.
Results and Discussion
Monitoring the extent of fungal burden in lung tissues. Independent imaging tools were used to 
monitor the development of aspergillosis. In vivo imaging was performed using positron emission tomography 
(PET) and computed tomography (CT). Although CT scans of the infected lungs indicated a pathology of an 
unknown etiology (non-physiological gray signs potentially revealing the presence of a tumor, inlammation or 
infection), the fused PET/CT images enabled us to observe the locations where 68Ga-doped TAFC was selectively 
captured by the fungus (Supplementary Fig. S1).
Grocott’s methenamine silver (GMS) and eosin staining was performed as another independent ex vivo tool 
and revealed extensive fungal burden in the infected animals, which was manifested by dense hyphae growth 
from the cell walls into the lumen of the trachea, bronchi/bronchioli and alveoli. Optical microscopy of the GMS 
and eosin-stained samples revealed the presence of intense black-colored Aspergillus hyphae in all infected bio-
logical replicates (Fig. 1a). Upon the application of the intratracheal spore suspension, the hyphae were present 
throughout the respiratory tract from the trachea to the terminal alveoli (Fig. 1b). Both sides were typically 
afected, although the spores were doped only on a single side. he hyphae penetrated the submucosal layer and 
ciliated epithelium towards the tracheal lumen. Fungal bodies also grew in the bronchioles, forming compacted 
assemblies (Fig. 1c,d). In the alveolar ducts and alveoli, the infection afected both the cell walls and the alveolar 
space and induced clogging and collapse of the lung tissue. We speculate that the lung collapse was the primary 
cause of host death. Hemorrhage was oten observed in areas afected by Aspergillus (Fig. 1e). he hyphae were 
also detected in the veins and arteries near the infected bronchioles (Fig. 1f).
Quantiication of the siderophores in rat serum. Upon lung inoculation, the immune system responds 
to the fungal growth and partially degrades the growing mycelia. Siderophore synthesis and iron uptake are 
Aspergillus virulence factors that occur at high frequencies19. A. fumigatus utilizes the following two systems 
for iron acquisition: siderophore-mediated iron uptake and reductive iron assimilation20. he fungus produces 
four known siderophores21. Fusarinin C and TAFC are excreted to chelate extracellular iron, whereas FC and 
hydroxy-ferricrocin are involved in hyphal and conidial intracellular iron storage. Using our rat model, we 
detected and monitored extracellular TAFC and intracellular FC (Fig. 2).
During infection in an immunocompromised host, the defense capacity is rapidly exhausted, and an encap-
sulated aspergilloma is formed. he growing fungal balls penetrate the lung wall, enabling the further transfer 
of fungal secondary metabolites into the blood. he binding of both siderophores to transport proteins has been 
reported to be low22. FC binds serum proteins at a higher capacity than TAFC, suggesting that its clearance from 
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serum could be slower. Indeed, in serum from six infected animals, we detected ferri-ferricrocin (Fe-FC) concen-
trations in the range of 3–32 ng/mL, which contrasted with ferri-triacetylfusarinine C (Fe-TAFC) concentrations 
that were below the detection limit (Supplementary Fig. S2). he mean value of Fe-FC was 12.52 ± 4.44 ng/mL 
(Supplementary Table S2). No siderophores were detected in the control animals. In our HPLC-electrospray 
ionization (ESI)-CASI-Fourier Transform Mass Spectrometry (FTMS) setup, the limits of detection (LODs) of 
Fe-TAFC and Fe-FC in the serum samples were 0.28 and 0.36 ng/mL, respectively (Supplementary Figs S3 and 
S4). Galactomannan (GM) results (Platelia Aspergillus EIA, Bio-Rad, Prague, Czech Republic) on the same serum 
Figure 1. Histological examination of rat lung tissue infected with Aspergillus fumigatus. GMS and eosin 
staining was used for the area deinition, which was examined in parallel by MALDI-MSI (dashed line in black). 
Fungal hyphae are marked by red arrows in all panels (a–f). Descriptors: A (arteriole), Al (alveoli), B (primary 
bronchus or bronchiole), E (esophagus), H (hemorrhage), T (trachea), V (vein), N (nervus vagus).
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samples conirmed the pathogen presence in all infected samples. One control sample (S14) was false positive 
(Supplementary Fig. S2, Panel B). In 1,3-β-D-glucan tests (Fungitell, Associates of Cape Cod, Falmouth, USA) all 
infected rat sera revealed 1,3-β-D-glucan concentrations >523 pg/mL. Two control samples were false positive 
(Supplementary Fig. S2, Panel C).
In previous work by Carrol et al., the reported TAFC concentration in human serum was in the ng/mL range15. 
When the sodiated and potassiated Fe-TAFC forms were monitored, the LOD in a multiple reaction monitoring 
experiment using a triple quadrupole instrument was determined to be 1 ng/mL. With a 0.1 Da extraction win-
dow, considerable chemical noise could cause false-positive indings; even a healthy individual could show a low 
TAFC level, which obviously cannot be the case. In our high mass resolution CASI experiment, better selectivity 
was achieved with a 0.01 Da width for ion chromatogram extraction. We obtained clean chromatograms at sidero-
phore concentration 0.1 ng/mL (Supplementary Fig. S5).
Towards non-invasive diagnoses of aspergillosis. Microbial siderophores are small molecules that are 
not captured by the kidney and can be efectively secreted in urine. Indeed, Fe-TAFC and Fe-FC were detected in 
urine from all infected animals (Fig. 3). Compared to the serum samples, the concentration levels of the sidero-
phores were much higher in urine, reaching concentrations as high as 1 µg/mL. he mean concentration values of 
Fe-TAFC and Fe-FC were 0.37 ± 0.17 and 0.63 ± 0.12 µg/mL, respectively. Statistical signiicance was conirmed 
by z-test for both molecules (Supplementary Table S5). In the rat urine the respective limits of detection were 
lower than those in serum and achieved 0.02 and 0.03 ng/mL, respectively.
Notably, all specimens (i.e., urine, serum, lung tissue) from all biological replicates were collected simultane-
ously on day 3 post-infection. In two animals (U8 and U12), the extracellular TAFC dominated the intracellular 
FC. In the other four animals, the mutual siderophore ratio was the opposite. herefore, none of these biomarkers 
can be distinguished as “early” or “late” with respect to the cellular location of the siderophore. In our rat model, 
the occurrence of Fe-FC is clearly more dominant than the concentration of Fe-TAFC. he mutual ratio can 
be afected not only by possible protein binding but also by the genetic equipment of the corresponding fungal 
producer. However, no signiicant diference was detected between the Fe-TAFC and Fe-FC concentrations at the 
0.05 signiicance level (Supplementary Table S6).
By contrast, the molecular detection of microbial siderophores in mammalian urine provides clear evidence 
of microbial infection in the host. he actual concentration can be a potential measure of the disease severity. he 
signiicant molecular speciicity and sensitive detection limits make our method a good candidate for transfer 
to human diagnostics. LC-CASI-FTMS monitoring has the potential to be used in future antifungal treatment 
monitoring, such as in patients sufering from chronic aspergillosis. Although the LC-CASI-FTMS approach is 
Figure 2. Structures of Fe-TAFC (let) and Fe-FC (right).
Figure 3. Proiling of Fe-TAFC and Fe-FC in urine from infected (let six) and control (right three) animals. 
Data were generated by liquid chromatography and CASI-FTICR mass spectrometry. Bound iron concentration 
data were obtained using solution ICP-MS.
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costly in terms of the required instrumental equipment, this approach is one of the most sensitive and speciic 
approaches developed to date that is capable of solving this task.
Analogous to the molecular markers, a similar trend was observed at the elemental level (Fig. 3). he induc-
tively coupled plasma mass spectrometry (ICP-MS) measurements revealed much higher distributions (1.58 ± 
0.25 µg/mL) of bound iron in infected animals than those in the controls (0.09 ± 0.01 µg/mL). his observation 
correlates well with our previous results of laser ablation ICP-MS of infected lung tissues, which also revealed 
similar chemical noise13.
Molecular description of invasive aspergillosis in lung tissues. MALDI-CASI-FTICR mass spec-
trometry can be a speciic molecular imaging tool for describing an infectious disease in rat lung tissue, resolving 
possible false-positive results obtained from light microscopy. To the best of our knowledge, this report is the irst 
of a true molecular MSI application in infectious disease diagnostics. he lungs are a low-density aerial tissue 
dominated by protonated or sodiated phosphocholines, namely, PC(32:0) and PC(34:1), in which the siderophore 
signals are buried (Supplementary Fig. S6).
To examine the siderophore distribution in the rat lung sections, we analyzed the area indicated in Fig. 1. 
Interestingly, the siderophore desferri-forms were the most abundant species in the MALDI-CASI-FTICR-MSI 
analysis. Notably, a low abundance of [M + Na]+ ions of FC was observed at m/z 740.3179, and the presence 
of many other species with diferent elemental compositions and mass defects were detected at the same (740) 
nominal mass (Fig. 4). Ferri-form signals were also detected, but these signals revealed even smaller absolute 
intensities.
A similar finding was observed with the potassiated desferri-FC variant (756.2919), which was shaded 
by phosphocholines extending up to 6 × 108 counts of absolute ion intensity. he absolute intensities of the 
[FC + Na]+ and [FC + K]+ ions ranged in the order of 106, whereas the corresponding ferri-forms were notably 
less abundant (104) (Supplementary Fig. S7).
he highest FC concentrations correlated well with areas with massive fungal burden as indicated by the 
histology analysis (Fig. 1). FC was also detected by MSI in areas that were not histologically predicted to be 
infected (Supplementary Fig. S7). herefore, mass spectrometry has a higher sensitivity than optical micros-
copy. Furthermore, GMS staining can lead to false-positive results. For instance, a polysaccharide structure was 
detected in the esophagus. Although these complex sugars were labeled in black by GMS, they were not markers 
of fungal infection (Fig. 5, top). he esophagus is not embedded into the lungs but is located parallel to the tra-
chea. In this case, the lungs were removed from the animal along with the esophagus, and upon tissue freezing, 
both tissue specimens remained together.
he presence of FC was inferred from both exact and product mass spectra measurements. MALDI tan-
dem mass spectrometry (MS/MS) of the infected tissue provided the same product ions as those reported for 
the standard sodiated FC (Supplementary Fig. S8). hese spectra revealed typical losses of C2H4O2 units14. For 
Figure 4. MALDI-CASI-FTICR mass spectrum of infected lung tissue with [FC + Na]+ ion signals (Panel A). 
Isotopic A + 1 ion is also labeled (m/z 741.3219). MALDI mass spectrum of control tissues does not reveal any 
fungal biomarkers (Panel B).
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additional characterization, we performed a dereplication of the microbial secondary metabolites provided by our 
in-house sotware, i.e., CycloBranch, which uses an integrated library of fungal secondary metabolites18. For this 
analysis, we implemented a new multimodal imaging module that enabled us to fuse imaging mass spectrometry 
data with histology and optical scans of the indium-tin oxide (ITO) MALDI plate. hus, relative siderophore 
distributions in the tissue sections were observed (Fig. 5, bottom). his open-source, cross-platform, stand-alone 
application, which was originally developed for the de novo sequencing of non-ribosomal peptides17, was recently 
applied to the de novo sequencing of cyclic and branch-cyclic siderophores containing polyketide building 
blocks18. A typical graphical output of sodiated desferri-FC sequenced de novo is illustrated in Supplementary 
Fig. S9. his sotware can be downloaded for free at http://ms.biomed.cas.cz/cyclobranch.
Finally, the extent of invasive aspergillosis in bulk tissue sections was also evaluated by quantitative mass 
spectrometry (Supplementary Fig. S10). he concentration of FC was determined in four infected animals (L1, 
L4, L11, L12); the FC concentration oscillated in the ppm range (mean 13.9 ± 7.5 µg/g and median 9.2 µg/g, dry 
weight), whereas the TAFC concentration was below the LOD. In poly[N-(2-hydroxypropyl)methacrylamide] 
(pHPMA)-illed lungs (L1, L4), the concentration of the siderophores was lower than that in intact lungs (L11, 
L12). Although the pHPMA polymer has been reported to be suitable for the ionization of peptides and proteins 
by MALDI23, in our siderophore application, we noticed interference resulting in siderophore signal reduction by 
approximately one order of magnitude. No siderophores were detected in the control animals.
Materials and Methods
Experimental model of aspergillosis in rats. Both the Aspergillus cultivation procedures and the exper-
imental model of aspergillosis have been described in detail elsewhere13. Briely, A. fumigatus 1059 CCF was 
obtained from the Culture Collection of Fungi, Faculty of Science, Charles University in Prague and maintained 
on yeast medium slants (0.3% malt extract, 0.3% yeast extract, 0.5% peptone, and 0.5% glucose) at 4 C°. All 
animal experiments were conducted in accordance with the regulations and guidelines of the Czech Animal 
Protection Act (No. 246/1992) with the approval of the Czech Ministry of Education, Youth and Sports (MSMT-
21235/2013-12) and the institutional Animal Welfare Committee of the Faculty of Medicine and Dentistry of 
Palacky University in Olomouc, Czech Republic. he studies were performed using two groups of female Lewis 
Figure 5. MALDI-CASI-FTICR-MS image (Bruker FlexImaging 4.1) of combined [FC + Na]+ and 
[FC + K]+ (±0.001 Da) distribution illuminated in green (A). Graphic output of our dereplication tool, i.e., 
CycloBranch, indicating the annotation of the siderophores (B)18.
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rats (2–3 months old, Harlan Laboratories). he irst group (twelve animals) included immunocompromised rats 
infected with Aspergillus. he second (control) group included three immunocompromised animals.
To prevent the animals from developing bacterial super-infection, all iteen animals (twelve infected and 
three controls) were treated with 2 mM ciproloxacin (Ciproloxacin Kabi, Fresenius Kabi, Czech Republic) and 
0.1 mM polymyxin E (Colomycin, Forest Laboratories, UK) in their drinking water throughout the experiment. 
Five days before the inoculation, the irst group received the immunosuppressive DNA-alkylating agent cyclo-
phosphamide (Endoxan, Baxter, Czech Republic, i.p., 75 mg/kg) and the antibiotic teicoplanin (Targocid, Sanoi, 
Czech Republic, i.m., 35 mg/kg). One day before the infection, the administration of both drugs was repeated 
with the following modiication: the teicoplanin dose was reduced to 25 mg/kg (i.m.). On the day of inocula-
tion, the administration of teicoplanin was repeated (25 mg/kg, i.m.), followed by an intratracheal application 
of Aspergillus spores (100 µL, 108 CFU/mL). he experiment was concluded (day 3 post-infection) based on the 
monitoring of the health status of each animal and our previous experience with a rat model of Aspergillus infec-
tion24. he control animals underwent the same treatment as the infected animals, except for the administration 
of the Aspergillus spores.
Six animals that were infected with Aspergillus died before day 3 post-infection and were excluded from the 
experiment. At the end of the experiment, the nine surviving animals were sacriiced by an overdose of a keta-
mine (Calypsol, Gedeon Richter, Hungary) and xylazine (Xylazin Ecuphar, Ecuphar, Germany) mixture (2:1). 
hree lung sample sets (L-samples) were compared as follows: collapsed infected lungs (L2, L11, L12), infected 
lungs inlated with the pHPMA polymer (L1, L4, L8)23, and lungs from control animals dosed only with the 
immunosuppressants (L13 with polymer, L14, L15). At the end of the experiment, the urine (U-samples) and 
serum (S-samples) were collected in parallel from all nine survivors.
Statistical analysis. The diversity in the technical replicates was measured by the coefficient of variation 
(Supplementary Table S1). he heterogeneity in the biological replicates is presented as the mean ± standard error 
of the mean and was assessed by the coeicient of variation (Supplementary Tables S2 and S3). Gaussian distribu-
tion of data sets was assessed by Jarque-Bera tests and Lilliefors corrected Kolmogorov-Smirnov tests (Supplementary 
Table S4). he normality assumption was not rejected, so the parametric statistics were used. he statistical analyses 
were performed using one-tailed z-tests under the null hypothesis that the Fe-TAFC, Fe-FC and iron concentrations 
were under the detection limit (Supplementary Table S5). he pair diferences within all three groups (Fe-TAFC, Fe-FC, 
iron) were subjected to the standard Student’s two-sample t-test to determine the statistical signiicance of the detected 
changes (Supplementary Table S6 and Fig. S11). he signiicance level was set at p < 0.05. Statistical analysis was per-
formed using Matlab sotware (MATLAB version 8.6 (R2015b), Natick, Massachusetts: he MathWorks Inc.).
Extraction, separation and quantiication of the siderophores. he siderophore extractions from 
urine, serum and lung tissues were performed according to the adapted protocol for metabolite proiling25. Briely, 
the urine samples (100 µL) were diluted with methanol (400 µL) to provide an approximately 80% inal metha-
nolic solution. he samples were gently shaken and incubated for 8 h at −80 °C. hen, the sample was centrifuged 
at 14,000 × g for 10 min (4–8 °C), and the supernatant was transferred to a new 1.5 mL microcentrifuge tube, 
lyophilized to dryness and stored at −80 °C. he serum samples were treated in the same way with the follow-
ing modiication: the sera (200 µL) were centrifuged in Amicon 3 kDa ultra centrifugal ilters (Millipore Sigma, 
Darmstadt, Germany). he third remaining sample type, the bulk lung tissues (19–50 mg) from the four infected 
and one control animal, was collected, dried and precisely weighed. Each sample was homogenized by milling 
with glass beads (1 mm diameter) in methanol (1 h). he supernatant was collected, the beads were decanted with 
methanol twice, and the extracts were pooled and dried.
Prior to the LC/MS analyses in triplicates, all samples prepared by extraction as indicated above were 
re-dissolved in water (50 µL) and loaded onto an Isolute ENV + SPE column (Labicom, Olomouc, Czech 
Republic). he charged contaminants were eluted with 50 mM ammonium acetate (pH 5.3), and the components 
of interest were extracted with 0.5 mL of methanol. he solutions were then dried and dissolved in 5% acetoni-
trile (100 µL) as the starting solvent. Each sample was loaded (20 µL loop) onto a BEH C18/1.7 µm, 2.1 × 5 mm 
VanGuard precolumn (Waters, Prague, Czech Republic) at a 50 µL/min low rate. he siderophores were then 
separated on analogous analytical columns (1 × 150 mm) with the following gradient: 0–2 min (2% B), 35 min 
(60% B), 38–40 min (95% B), and 41–50 min (2% B), where A and B represent 0.1% formic acid in water and 0.1% 
formic acid in acetonitrile, respectively.
he positive-ion ESI mass spectra were collected online using a 12 T SolariX FTICR mass spectrometer 
(Bruker Daltonics, Billerica, MA, USA). he ion source was operated at 4,500 V with drying gas (N2) at a 5 L/
min low rate. he end-plate ofset was adjusted to −200 V. he collision voltage and time-of-light values were 
−5 V and 1.2 ms, respectively. he mass spectra were collected in the CASI mode (700–1,000 m/z window) at an 
approximately 0.3 Hz frequency with a mass accuracy better than 3 ppm. he extracted ion chromatograms with 
0.01 Da spectral width were used for the integration.
he siderophores were quantiied using external matrix-matched calibration standards (EMC Microcollections 
GmbH, Tübingen, Germany) prepared from 0.1 ng/mL to 10 µg/mL. he Fe-TAFC and Fe-FC ranges were quan-
tiied by a weighted linear regression (1/x2) via three technical replicates according to the literature26. he LOD 
and LOQ were calculated as 3.3 × (SD/slope) and 10 × (SD/slope) in 0.1–100 ng/mL concentration intervals 
(SD represents the Standard Deviation), respectively. he responses were summed from the integrated areas 
of the ferri-forms of protonated, sodiated and potassiated species, which are represented by [M + Fe-2H]+ , 
[M + Fe + Na-3H]+ , and [M + Fe + K-3H]+ ions, respectively. The acquired spectra were analyzed using 
DataAnalysis 4.4 (Bruker Daltonics, Germany), converted using CompassXport 3.0 (Bruker Daltonics, Bremen, 
Germany) and processed with CycloBranch17,18.
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Lung cryosectioning, histological staining and MALDI imaging with semi-quantiication. he 
deeply frozen native infected and control lung tissue samples were allowed to warm to −13 °C prior to sectioning 
with a Leica cryomicrotome CM1950 (Leica, Germany). he tissues were cut into 15 µm-thick slices and mounted 
onto pre-cooled ITO glass slides (Bruker Daltonics, Bremen, Germany) for the MALDI-MSI experiments in at least 
two technical replicates. Consecutive slices used for the optical microscopy were thaw-mounted. Both slide types 
were vacuum-dried in a desiccator at room temperature for 40 min. Using a modified GMS staining procedure 
(Sigma-Aldrich kit, Germany), the fungal polysaccharide wall was oxidized with periodic acid to release the aldehyde 
groups. At a basic pH, these groups reacted with methenamine silver in the impregnation step, reducing it to metallic 
silver and rendering the fungal cells visible. he redundant silver was removed with a sodium thiosulfate solution. he 
tissue sample was then counterstained with Eosin Y (VWR Chemicals, Czech Republic), dehydrated using stepwise 
(95 and 100%) concentrations of ethanol, toned in xylene and ixed with DPX medium (Sigma-Aldrich, Germany). 
Alternatively, hematoxylin and eosin staining was used for the standard histopathological evaluation. In this case, the 
specimens were rehydrated, stained with hematoxylin Gill no. 2 (Sigma Aldrich, Czech Republic), lushed with water, 
and the excessive colorant was removed with acidic ethanol. Subsequently, eosin staining was performed. he same 
procedure was repeated as in the previous case. All specimens were evaluated under a DN45 light microscope (Lambda 
Prague, Prague, Czech Republic) equipped with a Canon EOS 700D camera.
The MALDI-MSI was performed using the same FTICR mass spectrometer in the CASI mode with a 
quadrupole-narrowing window in the 700–1,100 mass range. he matrices α-cyano-4-hydroxy-cinnamic acid 
(CHCA, 10 mg/mL in 50% ACN/0.1% TFA) and dihydroxybenzoic acid (DHB, 30 mg/mL in 50% ACN/0.1% 
TFA) were mixed at a 1:1 ratio and applied to the prepared tissues using an ImagePrep (Bruker Daltonics, Bremen, 
Germany, default method for CHCA) device. he siderophores were desorbed with a 50 µm raster step size using 
a SmartBeam II laser (2 kHz, 200 shots/pixel) and 320,000 resolution (FWHM) at m/z 400. he product ion 
mass spectra were collected at a 3 Da isolation width and 30 V collision energy. Desorption from the pure stand-
ards or tissues was performed using laser attenuations of 22% or 26%, respectively. he raw mass spectra were 
exported as an imzML ile using FlexImaging 4.1 (Bruker Daltonics, Bremen, Germany) and batch-processed 
using CycloBranch18 against the database of siderophores11. he product ion mass spectra were evaluated using 
DataAnalysis 4.4 (Bruker Daltonics, Bremen, Germany) sotware.
In this work, the siderophores are reported in both ferri- or desferri-forms. Siderophore ferri-protonated, 
ferri-sodiated and ferri-potassiated species are represented by [M + Fe-2H]+ , [M + Fe + Na-3H]+ , and 
[M + Fe + K-3H]+ , respectively. Analogous desferri-forms are reported as [M + H]+ , [M + Na]+ , and [M + K]+ , 
ions. he molecular descriptor M may represent any siderophore (FC or TAFC).
ICP-MS. he concentration of iron bound to the siderophores was quantiied in the urine by solution ICP-MS. 
he chemicals, reagents, procedures and instrumentation have been previously reported elsewhere13. In the 
urine samples, the free iron was removed by solid phase extraction on an Isolute ENV + SPE cartridge (Biotage, 
Olomouc, Czech Republic). he eluents were then precisely diluted with 1% (v/v) nitric acid to 3 mL. he iron 
content in the 0.1 to 10 µg/L range was measured using an Agilent 7700x ORS-ICP mass spectrometer (Agilent 
Technologies, Japan) equipped with an ASX-520 autosampler and octopole reaction system working in helium 
mode to overcome the spectral interferences observed on 56Fe and 57Fe isotopes.
Data availability. All data generated or analyzed in this study are included in this published article and its 
supplementary information iles. Original raw datailes can be downloaded from this persistent web link: https://
owncloud.cesnet.cz/index.php/s/GzxKD094iYVQbyr.
Conclusions
Aspergillus fumigatus produces a diverse set of mycotoxins and secondary metabolites that can be used as disease 
biomarkers in an infected host. he spectrum of these microbial products is dependent on the Aspergillus species 
and on the cultivation or stress conditions. he excretion of fungal virulence factors is expected to be high during 
the early stages of infection. For example, gliotoxin9 or fungal siderophore production is essential for Aspergillus 
strain virulence12. Because siderophores are not synthesized by mammalian hosts, the detection of fungal metab-
olites in an infected host is a valid diagnostic assay rather than simply a conirmatory approach.
In this work, we identiied two microbial siderophores, i.e., FC and TAFC, as markers of IPA infection that 
can be non-invasively detected in urine from an infected host. hese molecules can be detected in the ferri- or 
desferri-forms. In addition, their combinations with sodium and potassium ions were also observed in the serum 
and lung tissue samples, making siderophore quantiication more challenging. We provided robust qualitative and 
quantitative data indicating the strong analytical potential of the CASI-FTICR approach. he best results were 
obtained in the HPLC-ESI-CASI-FTICR experiments. he LODs of Fe-TAFC and Fe-FC in the rat serum were 
0.28 and 0.36 ng/mL, respectively. In the rat urine the respective limits of detection were lower and achieved 0.02 
and 0.03 ng/mL. In the infected animals, ferricrocin concentrations in the rat sera luctuated in the 3–32 ng/mL 
range. Importantly, the biomarker concentrations were much higher in the urine and could reach up to 1 µg/mL. 
he siderophore concentration in the bulk lung tissues was in the ppm range (µg of siderophore/g of tissue). In 
the tissue assessment, the molecular speciicity of MSI could outperform optical microscopy with GMS staining, 
clarifying its false-positive and false-negative results. Furthermore, the iron concentration (siderophore-bound) 
in the urine from infected animals was approximately 17 × higher than that in the controls (assessed in the solu-
tion ICP-MS experiments). In contrast to the less-speciic bound iron detection, the molecular quantiication has 
a much better speciicity as the siderophores revealed no or little chemical background.
TAFC and FC are panfungal markers, as their production was described with some other microbial genera. 
e.g. Fusarium graminearum, Fusarium sacchari, Paracoccidioides or Pseudogymnoascus species27,28. On the con-
trary, namely A. fumigatus and A. nidulans could be considered as important siderophore producers that are most 
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clinically relevant29. Galactomannan30 as well as 1,3-β-D-glucan tests31 may exhibit poor positive predictive value 
(Supplementary Fig. S2). he low limit of detection of TAFC and FC in serum or urine and high positive predic-
tive value of the test based on siderophores may improve the overall diagnostic accuracy of aspergillosis detection, 
either alone or in concert with other non-invasive or invasive diagnostic armory.
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Figure S7. MALDIMSI revealed lower abundance of [FC+Fe+Na-3H]+ and [FC+Fe+K-3H]+ ions (m/z 793 and 809) compared
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Figure S8. Product ion MALDI mass spectra of the [FC+Na]+ ion. (A) FC standard received from EMC Microcollections,
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permitted the dissociation of interfering contaminants having their m/z value close to the siderophore parent.
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Figure S9. Screenshot of the de novo sequencing result on [FC+Na]+ returned by CycloBranch. For the graphics description,
please, see the webpage http://ms.biomed.cas.cz/cyclobranch.
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Table S1. The variabilities in technical replication measured by the coefficient of variation (CV).
Mean CV Standard error of the mean (SEM)
Urine Fe-TAFC 0.0333 0.0080
Urine Fe-FC 0.0387 0.0045
Urine bound iron 0.0693 0.0119
Serum Fe-FC 0.0946 0.0467
Lung Fe-FC 0.3277 0.1704
Table S2. The variabilities in biological replicates measured by the coefficient of variation (CV) in six infected animals. SEM
is the standard error of the mean.
Limit of detection Mean ±SEM CV
Urine Fe-TAFC 0.02 ng/mL 0.3674 µg/mL 0.1655 µg/mL 1.1036
Urine Fe-FC 0.03 ng/mL 0.6272 µg/mL 0.1154 µg/mL 0.4506
Urine bound iron 0.03 µg/mL 1.5784 µg/mL 0.2532 µg/mL 0.3929
Serum Fe-FC 0.36 ng/mL 12.5245 ng/mL 4.4407 ng/mL 0.8685
Lung Fe-FC 0.36 µg/g 13.8725 µg/g 7.5491 µg/g 1.0884
Table S3. The variabilities in biological replication measured by the coefficient of variation (CV) in three control animals.
SEM is the standard error of the mean.
Mean ±SEM CV
Urine bound iron 0.0930 µg/mL 0.0067 µg/mL 0.1248
Table S4. Skewness, kurtosis, and p-values of normality tests for infected groups. Gaussian distribution of data sets was
assessed by Jarque-Bera tests and Lilliefors corrected Kolmogorov-Smirnov tests.
Skewness Kurtosis P-value for Jarque–Bera test P-value for Lilliefors corrected
Kolmogorov-Smirnov test
Urine Fe-TAFC 0.6499 1.4997 0.1287 0.0377
Urine Fe-FC 1.2600 3.3559 0.0458 0.0530
Urine Bound iron 0.3757 1.5390 0.3584 0.1697
Serum Fe-FC 0.9390 2.4397 0.1355 0.1216
Lung Fe-FC 0.7229 1.8996 0.3267 0.5000
Table S5. The statistical analyses performed using one-tailed z-tests under the null hypothesis claiming that the expected value
is under the limit of detection (NAN stands for Not A Number).
P-values
Infected Control
Urine Fe-TAFC 0.0132 NAN
Urine Fe-FC <0.0001 NAN
Urine Bound iron <0.0001 <0.0001
Serum Fe-FC 0.0024 NAN
Lung Fe-FC 0.0367 NAN
Table S6. The p-values returned by a standard Student’s two-sample t-test.
Metabolite pairs P-value
Urine Fe-TAFC vers. Fe-FC 0.2304
Fe-TAFC vers. Bound iron 0.0034
Fe-FC vers. Bound iron 0.0112
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